Santen Pharmaceutical Co. Ltd. is a Japan-based company dedicated exclusively to ophthalmology. It develops, manufactures, and markets prescription eye care medicines focused on improving vision-related quality of life through specialized research and strong engagement with eye care professionals worldwide.
Santen provides pharmaceutical solutions for glaucoma, retinal diseases, dry eye, and ocular inflammation. Its products are developed through focused ophthalmic research and distributed via hospitals and specialist clinics. The company emphasizes physician education and clinical collaboration to support effective eye disease management.
Sustainability at Santen is guided by patient-centric innovation, ethical governance, and responsible operations. The company focuses on quality assurance, environmental compliance, and social responsibility, while supporting eye health awareness and access initiatives aligned with long-term healthcare value creation.
Santen operates in more than 60 countries across Asia, Europe, and the Americas. Its global presence includes research facilities, manufacturing plants, and commercial offices, enabling specialized ophthalmic care delivery across developed and emerging healthcare markets.
Further Details
Some additional details about the company are listed below:
| Parameter | Details |
|---|---|
| Santen Pharmaceutical Co. Ltd. | https://www.santen.com/ |
| Company Name | Santen Pharmaceutical Co. Ltd. |
| Application Areas | Glaucoma, retinal diseases, ocular inflammation |
| Sustainability Recognition | Focus on long-term eye health and responsible innovation |
| Key Technologies | Ophthalmic drug formulation, eye disease research |
| Industry | Ophthalmic Pharmaceuticals |
| Core Focus | Research and development of eye care medicines |
| Solutions Offered | Prescription ophthalmic drugs, eye disease treatments |